{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:12:50Z","timestamp":1768997570772,"version":"3.49.0"},"reference-count":141,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T00:00:00Z","timestamp":1451433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The cholesterol pathway is an essential biochemical process aimed at the synthesis of bioactive molecules involved in multiple crucial cellular functions. The end products of this pathway are sterols, such as cholesterol, which are essential components of cell membranes, precursors of steroid hormones, bile acids and other molecules such as ubiquinone. Several diseases are caused by defects in this metabolic pathway: the most severe forms of which cause neurological involvement (psychomotor retardation and cerebellar ataxia) as a result of a variety of cellular impairments, including mitochondrial dysfunction. These pathologies are induced by convergent mechanisms in which the mitochondrial unit plays a pivotal role contributing to defective apoptosis, autophagy and mitophagy processes. Unraveling these mechanisms would contribute to the development of effective drug treatments for these disorders. In addition, the development of biochemical models could have a substantial impact on the understanding of the mechanism of action of drugs that act on this pathway in multifactor disorders. In this review we will focus in particular on inhibitors of cholesterol synthesis, mitochondria-targeted drugs and inhibitors of the inflammasome.<\/jats:p>","DOI":"10.3390\/ijms17010047","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T10:25:05Z","timestamp":1451471105000},"page":"47","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3427-618X","authenticated-orcid":false,"given":"Annalisa","family":"Marcuzzi","sequence":"first","affiliation":[{"name":"Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, Trieste 34128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7374-1684","authenticated-orcid":false,"given":"Elisa","family":"Piscianz","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health\u2014IRCCS \u201cBurlo Garofolo\u201d, via dell\u2019Istria, 65\/1, Trieste 34137, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1096-042X","authenticated-orcid":false,"given":"Claudia","family":"Loganes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, Trieste 34128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza","family":"Vecchi Brumatti","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health\u2014IRCCS \u201cBurlo Garofolo\u201d, via dell\u2019Istria, 65\/1, Trieste 34137, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Knowles","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health\u2014IRCCS \u201cBurlo Garofolo\u201d, via dell\u2019Istria, 65\/1, Trieste 34137, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrine","family":"Bilel","sequence":"additional","affiliation":[{"name":"Cluster in Biomedicine (CBM scrl), Trieste 34128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Tommasini","sequence":"additional","affiliation":[{"name":"Institute for Maternal and Child Health\u2014IRCCS \u201cBurlo Garofolo\u201d, via dell\u2019Istria, 65\/1, Trieste 34137, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Bortul","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, Trieste 34128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Zweyer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, Trieste 34128, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.bbalip.2013.03.003","article-title":"Regulation of mevalonate metabolism in cancer and immune cells","volume":"1831","author":"Thurnher","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0022-2275(20)34935-X","article-title":"Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways","volume":"38","author":"Hinson","year":"1997","journal-title":"J. Lipid Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1568006013338187","article-title":"Pleiotropic effects of statins on the vascular tissue","volume":"1","author":"Ikeda","year":"2001","journal-title":"Curr. Drug Targets Cardiovasc. Haematol. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10409238.2010.485605","article-title":"Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase","volume":"45","author":"Jo","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8929","DOI":"10.1016\/S0021-9258(18)68397-8","article-title":"Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme","volume":"263","author":"Nakanishi","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0968-0004(96)80168-X","article-title":"The biology of HMG-CoA reductase: The pros of contra-regulation","volume":"21","author":"Hampton","year":"1996","journal-title":"Trends Biochem. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1358\/dot.2003.39.2.740209","article-title":"Modulation of the inflammatory process by statins","volume":"39","author":"Crisby","year":"2003","journal-title":"Drugs Today"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0022-2275(20)34418-7","article-title":"Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol","volume":"25","author":"Goldstein","year":"1984","journal-title":"J. Lipid Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/B978-0-444-59565-2.00054-X","article-title":"Cholesterol metabolism deficiency","volume":"113","author":"Jira","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00011-010-0168-6","article-title":"Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency","volume":"59","author":"Marcuzzi","year":"2010","journal-title":"Inflamm. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1093\/hmg\/ddg072","article-title":"Disorders of cholesterol biosynthesis: Prototypic metabolic malformation syndromes","volume":"12","author":"Herman","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1203\/PDR.0b013e3181761870","article-title":"Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency","volume":"64","author":"Marcuzzi","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00281-015-0492-6","article-title":"Hyper-IgD syndrome\/mevalonate kinase deficiency: What is new?","volume":"37","author":"Simon","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2007.00915.x","article-title":"Genetic heterogeneity of autosomal dominant hypercholesterolemia","volume":"73","author":"Varret","year":"2008","journal-title":"Clin. Genet."},{"key":"ref_16","first-page":"1087","article-title":"Hyperimmunoglobulinaemia D and periodic fever: A new syndrome","volume":"1","author":"Vossen","year":"1984","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMra010200","article-title":"Hereditary periodic fever","volume":"345","author":"Drenth","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ajmg.1320280324","article-title":"Smith-Lemli-Opitz (RSH) syndrome bibliography","volume":"28","author":"Opitz","year":"1987","journal-title":"Am. J. Med. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199401133300205","article-title":"Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome","volume":"330","author":"Tint","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3101(23)00093-2","article-title":"Inborn errors of cholesterol biosynthesis","volume":"47","author":"Kelley","year":"2000","journal-title":"Adv. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-genom-091212-153412","article-title":"Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease","volume":"15","author":"Platt","year":"2014","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/10350","article-title":"Mutations in a delta 8-\u03947 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata","volume":"22","author":"Derry","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-3476(68)80247-1","article-title":"Unilateral limb and skin deformities with congenital heart disease in two siblings: A lethal syndrome","volume":"73","author":"Falek","year":"1968","journal-title":"J. Pediatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00442399","article-title":"The CHILD syndrome. Congenital hemidysplasia with ichthyosiform erythroderma and limb defects","volume":"134","author":"Happle","year":"1980","journal-title":"Eur. J. Pediatr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ajmg.1320290321","article-title":"A new autosomal recessive lethal chondrodystrophy with congenital hydrops","volume":"29","author":"Greenberg","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1086\/342668","article-title":"Lathosterolosis, a novel multiple-malformation\/mental retardation syndrome due to deficiency of 3\u03b2-hydroxysteroid-\u03945-desaturase","volume":"71","author":"Corso","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S","article-title":"Clinical phenotype of desmosterolosis","volume":"75","author":"FitzPatrick","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/323473","article-title":"Mutations in the 3\u03b2-hydroxysterol \u039424-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis","volume":"69","author":"Waterham","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2936","article-title":"Emerging inflammasome effector mechanisms","volume":"11","author":"Lamkanfi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clim.2012.12.006","article-title":"Specific inflammasomes in complex diseases","volume":"147","author":"Masters","year":"2013","journal-title":"Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.molcel.2007.01.032","article-title":"Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation","volume":"25","author":"Faustin","year":"2007","journal-title":"Mol. Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/glia.22499","article-title":"Human astrocytes express a novel NLRP2 inflammasome","volume":"61","author":"Minkiewicz","year":"2013","journal-title":"Glia"},{"key":"ref_36","first-page":"15","article-title":"Targeting the NLRP3 inflammasome in chronic inflammatory diseases: Current perspectives","volume":"8","author":"Ozaki","year":"2015","journal-title":"J. Inflamm. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature11250","article-title":"NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens","volume":"488","author":"Anand","year":"2012","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2012.02.001","article-title":"An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages","volume":"36","author":"Khare","year":"2012","journal-title":"Immunity"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1189\/jlb.3RU0514-265RR","article-title":"The multifaceted nature of NLRP12","volume":"96","author":"Tuncer","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.coi.2015.01.010","article-title":"The NAIP\/NLRC4 inflammasomes","volume":"32","author":"Vance","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/imr.12285","article-title":"NLRP3 at the interface of metabolism and inflammation","volume":"265","author":"Haneklaus","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1100613","article-title":"Cutting edge: Reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome","volume":"187","author":"Bauernfeind","year":"2011","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"8","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.4049\/jimmunol.1202479","article-title":"Cutting edge: Nitric oxide inhibits the NLRP3 inflammasome","volume":"189","author":"Tsuchiya","year":"2012","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Caito, S.W., and Aschner, M. (2015). Mitochondrial redox dysfunction and environmental exposures. Antioxid. Redox Signal.","DOI":"10.1089\/ars.2015.6289"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sorriento, D., Pascale, A.V., Finelli, R., Carillo, A.L., Annunziata, R., Trimarco, B., and Iaccarino, G. (2014). Targeting mitochondria as therapeutic strategy for metabolic disorders. Sci. World J., 2014.","DOI":"10.1155\/2014\/604685"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"H1417","DOI":"10.1152\/ajpheart.00089.2013","article-title":"Role of mitochondrial oxidative stress in hypertension","volume":"305","author":"Dikalov","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_49","first-page":"2741","article-title":"Is oxidative stress a therapeutic target in cardiovascular disease?","volume":"22","author":"Gori","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/1871529X11202020106","article-title":"Mitochondrial dysfunction, oxidative stress and diabetic cardiovascular disorders","volume":"12","author":"Shen","year":"2012","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.110.218966","article-title":"DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome","volume":"107","author":"Mercer","year":"2010","journal-title":"Circ. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/01.RES.0000258450.44413.96","article-title":"Mitochondrial dysfunction in atherosclerosis","volume":"100","author":"Madamanchi","year":"2007","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/15216540601178091","article-title":"Mitochondrial energy metabolism and redox state in dyslipidemias","volume":"59","author":"Vercesi","year":"2007","journal-title":"IUBMB Life"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.0910258107","article-title":"Dysregulation of the mevalonate pathway promotes transformation","volume":"107","author":"Clendening","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","first-page":"746","article-title":"Dysregulation of cholesterol balance in the brain: Contribution to neurodegenerative diseases","volume":"6","author":"Vance","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tem.2015.03.004","article-title":"Mitochondria in autoinflammation: Cause, mediator or bystander?","volume":"26","author":"Boes","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.redox.2014.12.003","article-title":"Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy","volume":"4","author":"Despouy","year":"2015","journal-title":"Redox Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mito.2013.01.008","article-title":"Mitochondrial metabolism of reactive oxygen species","volume":"13","author":"Venditti","year":"2013","journal-title":"Mitochondrion"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1038\/sj.onc.1202581","article-title":"Caspases: The proteases of the apoptotic pathway","volume":"17","author":"Benedict","year":"1998","journal-title":"Oncogene"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"23274","DOI":"10.3390\/ijms141223274","article-title":"Mevalonate kinase deficiency and neuroinflammation: Balance between apoptosis and pyroptosis","volume":"14","author":"Tricarico","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Marcuzzi, A., Tricarico, P.M., Piscianz, E., Kleiner, G., Vecchi Brumatti, L., and Crovella, S. (2013). Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line. Cell Death Dis., 4.","DOI":"10.1038\/cddis.2013.112"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2011.09.046","article-title":"Mitochondrial ROS generation for regulation of autophagic pathways in cancer","volume":"414","author":"Li","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/auto.7.3.14502","article-title":"Mitochondria removal by autophagy","volume":"7","author":"Wang","year":"2011","journal-title":"Autophagy"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/icb.2014.75","article-title":"Keeping the immune system in check: a role for mitophagy","volume":"93","author":"Lazarou","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/bies.201000073","article-title":"Mitochondria and the culture of the Borg: Understanding the integration of mitochondrial function within the reticulum, the cell, and the organism","volume":"32","author":"Braschi","year":"2010","journal-title":"Bioessays"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4939-1875-1_15","article-title":"Mitophagy and mitochondrial balance","volume":"1241","author":"Patergnani","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJMra1205406","article-title":"Autophagy in human health and disease","volume":"368","author":"Choi","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_70","first-page":"431","article-title":"Elevated autophagy and mitochondrial dysfunction in the Smith-Lemli-Opitz Syndrome","volume":"1","author":"Chang","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"27757","DOI":"10.1074\/jbc.M114.571810","article-title":"Unprenylated RhoA contributes to IL-1\u03b2 hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity","volume":"289","author":"Pervolaraki","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1074\/jbc.M113.536920","article-title":"Defects in mitochondrial clearance predispose human monocytes to interleukin-1\u03b2 hypersecretion","volume":"289","author":"Nijhuis","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.2174\/138161212803530835","article-title":"Mevalonate kinase deficiency: Disclosing the role of mevalonate pathway modulation in inflammation","volume":"18","author":"Marcuzzi","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors","volume":"41","author":"Williams","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The discovery and development of HMG-CoA reductase inhibitors","volume":"33","author":"Endo","year":"1992","journal-title":"J. Lipid Res."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Ghavami, S, Yeganeh, B., Stelmack, G.L., Kashani, H.H., Sharma, P., Cunnington, R., Rattan, S., Bathe, K., Klonisch, T., and Dixon, I.M. (2012). Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts. Cell Death Dis., 3.","DOI":"10.1038\/cddis.2012.61"},{"key":"ref_77","first-page":"4","article-title":"Current drug treatments for lipid management","volume":"9S","author":"Stone","year":"2002","journal-title":"Manag. Care"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Bandeali, S.J., Daye, J., and Virani, S.S. (2014). Novel therapies for treating familial hypercholesterolemia. Curr. Atheroscler. Rep., 16.","DOI":"10.1007\/s11883-013-0382-0"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2015.03.016","article-title":"Cardiovascular drug development: Is it dead or just hibernating?","volume":"65","author":"Fordyce","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2174\/1381612820666141013134447","article-title":"Adverse effects of statins\u2014Myths and reality","volume":"21","author":"Reiner","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Pirillo, A., and Catapano, A.L. (2015). Statin intolerance: Diagnosis and remedies. Curr. Cardiol. Rep., 17.","DOI":"10.1007\/s11886-015-0582-z"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/eci.12461","article-title":"The role of mitochondria in statin-induced myopathy","volume":"45","author":"Apostolopoulou","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Izadpanah, R., Sch\u00e4chtele, D.J., Pfn\u00fcr, A.B., Lin, D., Slakey, D.P., Kadowitz, P.J., and Alt, E.U. (2015). The impact of statins on biological characteristics of stem cells provides a novel explanation for their pleotropic beneficial and adverse clinical effects. Am. J. Physiol. Cell Physiol.","DOI":"10.1152\/ajpcell.00406.2014"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","article-title":"New insights into the molecular mechanisms of action of bisphosphonates","volume":"9","author":"Rogers","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"1","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2007.05.075","article-title":"Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells","volume":"570","author":"Merrella","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1359\/jbmr.1997.12.9.1358","article-title":"Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5\u2032-(\u03b2,\u03b3-dichloromethylene) triphosphate, by mammalian cells in vitro","volume":"12","author":"Frith","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1124\/mol.61.5.1255","article-title":"Further insight into mechanism of action of clodronate: Inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite","volume":"5","author":"Lehenkari","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"ref_90","first-page":"475","article-title":"Adverse effects of bisphosphonates: Current issues","volume":"5","author":"Diel","year":"2007","journal-title":"J. Support. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM200310233491721","article-title":"Renal failure with the use of zoledronic acid","volume":"349","author":"Chang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_92","first-page":"534","article-title":"Differences in nephrotoxicity of intravenous bisphosphonates for the treatment of malignancy-related bone disease","volume":"29","author":"Bergner","year":"2006","journal-title":"Onkologie"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1359\/jbmr.2000.15.1.147","article-title":"Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations","volume":"15","author":"Pecherstorfer","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s002239900353","article-title":"An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates","volume":"61","author":"Sauty","year":"1997","journal-title":"Calcif. Tissue Int."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: A randomized, Phase III, double-blind, placebo-controlled trial","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/107999003322558782","article-title":"Fever after zoledronic acid administration is due to increase in TNF-\u03b1 and IL-6","volume":"23","author":"Dicuonzo","year":"2003","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1359\/JBMR.0301230","article-title":"Statins prevent bisphosphonate induced \u03b3, \u0394-T-cell proliferation and activation in vitro","volume":"19","author":"Thompson","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/14740338.1.1.71","article-title":"The gastrointestinal tolerability and safety of oral bisphosphonates","volume":"1","author":"Marshall","year":"2002","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis: An American academy of oral medicine position paper","volume":"136","author":"Migliorati","year":"2005","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/14728214.13.2.309","article-title":"Emerging lipid-lowering drugs: Squalene synthase inhibitors","volume":"13","author":"Elsayed","year":"2008","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/CIRCULATIONAHA.111.028571","article-title":"Squalene synthase inhibitor lapaquistat acetate: Could anything be better than statins?","volume":"123","author":"Liao","year":"2011","journal-title":"Circulation"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/153537020422900701","article-title":"Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention","volume":"229","author":"Mo","year":"2004","journal-title":"Exp. Biol. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1203\/PDR.0b013e31821b581c","article-title":"The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency","volume":"70","author":"Marcuzzi","year":"2011","journal-title":"Pediatr. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/iub.1147","article-title":"Mitochondria as a pharmacological target: Magnum overview","volume":"65","author":"Olszewska","year":"2013","journal-title":"IUBMB Life"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Cochem\u00e9, H.M., Kelso, G.F., James, A.M., Ross, M.F., Trnka, J., Mahendiran, T., Asin-Cayuela, J., Blaikie, F.H., Manas, A.R., and Porteous, C.M. (2007). Mitochondrial targeting of quinones: Therapeutic implications. Mitochondrion, S94\u2013S102.","DOI":"10.1016\/j.mito.2007.02.007"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"37575","DOI":"10.1074\/jbc.M404003200","article-title":"Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis","volume":"279","author":"Dhanasekaran","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1432-1327.1999.00543.x","article-title":"Selective targeting of an antioxidant to mitochondria","volume":"263","author":"Smith","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Reddy, P.H. (2006). Mitochondrial oxidative damage in aging and Alzheimer\u2019s disease: Implications for mitochondrially targeted antioxidant therapeutics. J. Biomed. Biotechnol., 3.","DOI":"10.1155\/JBB\/2006\/31372"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1074\/jbc.M009093200","article-title":"Selective targeting of a redox-active ubiquinone to mitochondria within cells: Antioxidant and antiapoptotic properties","volume":"276","author":"Kelso","year":"2001","journal-title":"J. Biol Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm1001-1111","article-title":"Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells","volume":"7","author":"Hwang","year":"2001","journal-title":"Nat. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1474-9728.2003.00040.x","article-title":"MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress","volume":"2","author":"Saretzki","year":"2003","journal-title":"Aging Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/01.RES.0000070882.81508.FC","article-title":"Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia","volume":"92","author":"Schafer","year":"2003","journal-title":"Circ. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.molbrainres.2003.12.009","article-title":"Manganese potentiates lipopolysaccharide-induced expression of NOS2 in C6 glioma cells through mitochondrial-dependent activation of nuclear factor \u03baB","volume":"122","author":"Barhoumi","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20050285","article-title":"Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: Role of mitochondrial reactive oxygen species and calcium","volume":"389","author":"Kalivendi","year":"2005","journal-title":"Biochem. J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"C1440","DOI":"10.1152\/ajpcell.00607.2004","article-title":"Inhibition of complex I of the electron transport chain causes view the MathML sourceO2\u2014Mediated mitochondrial outgrowth","volume":"288","author":"Koopman","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/sj.cdd.4401685","article-title":"Long-distance apoptotic killing of cells is mediated by hydrogen peroxide in a mitochondrial ROS-dependent fashion","volume":"12","author":"Pletjushkina","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2005.06.030","article-title":"Mitochondrially targeted vitamin E and vitamin E mitigate ethanol-mediated effects on cerebellar granule cell antioxidant defense systems","volume":"1052","author":"Pan","year":"2005","journal-title":"Brain Res."},{"key":"ref_118","first-page":"222","article-title":"Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology","volume":"70","author":"Ross","year":"2005","journal-title":"Biochemistry"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.bi.46.070177.002255","article-title":"Hydroquinone dehydrogenases","volume":"46","author":"Crane","year":"1977","journal-title":"Annu. Rev. Biochem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0076-6879(94)34104-4","article-title":"Assay of ubiquinones and ubiquinols as antioxidants","volume":"234","author":"Kagan","year":"1994","journal-title":"Methods Enzymol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"21462","DOI":"10.1016\/S0021-9258(20)88204-0","article-title":"Mitochondrial electron transport-linked tocopheroxyl radical reduction","volume":"264","author":"Maguire","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_122","first-page":"241","article-title":"The mode of action of lipid-soluble antioxidants in biological membranes: Relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles","volume":"3","author":"Ernster","year":"1992","journal-title":"BioFactors"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1073\/pnas.90.1.45","article-title":"Autoxidation of lipids and antioxidation by \u03b1-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: Unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein","volume":"90","author":"Ingold","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1096\/fj.03-0240fje","article-title":"Mitochondria targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants","volume":"17","author":"Jauslin","year":"2003","journal-title":"FASEB J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"16510","DOI":"10.1074\/jbc.M301089200","article-title":"Redox regulation of cAMP-responsive element-binding protein and induction of manganous superoxide dismutase in nerve growth factordependent cell survival","volume":"278","author":"Bedogni","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.RES.0000109416.56608.64","article-title":"Decrease in mitochondrial complex I activity in ischemic\/reperfused rat heart: involvement of reactive oxygen species and cardiolipin","volume":"94","author":"Paradies","year":"2004","journal-title":"Circ. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0931245100","article-title":"Delivery of bioactive molecules to mitochondria in vivo","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1096\/fj.05-3718com","article-title":"Targeting an antioxidant to mitochondria decreases cardiac ischemia reperfusion injury","volume":"19","author":"Adlam","year":"2005","journal-title":"FASEB J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3109\/0886022X.2013.815107","article-title":"Mitochondria-targeted peptides prevent on contrast-induced acute kidney injury in the rats with hypercholesterolemia","volume":"35","author":"Duan","year":"2013","journal-title":"Ren. Fail."},{"key":"ref_130","first-page":"3","article-title":"Mitochondrial oxidative stress in aging and healthspan","volume":"1","author":"Dai","year":"2014","journal-title":"Longev. Healthspan"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"McCormack, W.J., Parker, A.E., and O\u2019Neill, L.A. (2009). Toll-like receptors and NOD-like receptors in rheumatic diseases. Arthritis Res. Ther., 11.","DOI":"10.1186\/ar2729"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1073\/pnas.1424741112","article-title":"Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance","volume":"112","author":"Carta","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4161\/auto.28374","article-title":"Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer","volume":"10","author":"Guo","year":"2014","journal-title":"Autophagy"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J. Cell. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/FJC.0000000000000053","article-title":"A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse","volume":"63","author":"Marchetti","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF02256431","article-title":"HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages","volume":"10","author":"Huang","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10545-011-9445-y","article-title":"Protein farnesylation and disease","volume":"35","author":"Novelli","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggart","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","article-title":"Rho GTPases, statins, and nitric oxide","volume":"97","author":"Rikitake","year":"2005","journal-title":"Circ. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMcibr1412016","article-title":"Cholesterol metabolism and immunity","volume":"371","author":"Simon","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/1\/47\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:55:02Z","timestamp":1760216102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/1\/47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,30]]},"references-count":141,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"alternative-id":["ijms17010047"],"URL":"https:\/\/doi.org\/10.3390\/ijms17010047","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,30]]}}}